SCHEMBL28525316

SCHEMBL28525316

COc1ccc(CSc2cc(O[SiH](C)C)cc(Cl)c2C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.40
DAO P14920 1/20 0.39
MAOB P27338 3/20 0.39
LMNA P02545 1/20 0.38
MMP13 P45452 1/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MAOA P21397 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2E1 P05181 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30080019 0.80 DAO (0.44) APPDAOMAOBLMNAMMP13
SCHEMBL28515776 0.80 DAO (0.44) APPDAOMAOBLMNAMMP13
SCHEMBL30079983 0.78 LMNA (0.38) APPMAOBLMNAMMP13TSHR
SCHEMBL10687383 0.72 APP (0.58) APPDAOMAOBLMNAMMP13
SCHEMBL22208974 0.69 IDO1 (0.46) APPDAOMAOBLMNAMMP13
SCHEMBL28522875 0.68 APP (0.45) APPDAOMAOBLMNAMMP13
SCHEMBL9507201 0.68 APP (0.46) APPDAOMAOBLMNAMMP13
SCHEMBL15211340 0.68 MAOB (0.45) APPDAOMAOBLMNAMMP13
SCHEMBL12454620 0.68 LMNA (0.50) APPLMNAMMP13TSHRALDH1A1
SCHEMBL19297784 0.67 APP (0.49) APPDAOMAOBLMNAMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112204036-B Macrocyclic fused pyrazoles as MCL-1 inhibitors 苏州亚盛药业有限公司 2022-12-27 CN disclosed
CN-112204036-A Macrocyclic fused pyrazoles as MCL-1 inhibitors 苏州亚盛药业有限公司 2021-01-08 CN disclosed